At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
Departed
Cindy Kent
Director
Accolade, Inc.
Effective
2025-04-08
Filed
April 8, 2025, 7:59 PM ET
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
Departed
Rajeev Singh
Other Named Officer
Accolade, Inc.
Effective
2025-04-08
Filed
April 8, 2025, 7:59 PM ET
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
Departed
Jeff Brodsky
Director
Accolade, Inc.
Effective
2025-04-08
Filed
April 8, 2025, 7:59 PM ET
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
Departed
Pat Wadors
Director
Accolade, Inc.
Effective
2025-04-08
Filed
April 8, 2025, 7:59 PM ET
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
Kenneth E. Ludlum has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 7, 2025.
On April 2, 2025, Chimera Investment Corporation (the “Company”) and Dan Thakkar mutually agreed that Mr. Thakkar will step down from his position as the Company’s Chief Credit & Risk Officer, effective July 1, 2025
Departed
David B. Fountain
Executive Vice President, General Counsel and Corporate Secretary
On April 8, 2025, Mr. Earl Collier, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), informed the Board he will not stand for re-election to the Board following the Annual Meeting of Shareholders which is scheduled to occur on May 22, 2025.
Departed
(interim)
Kanwardev Raja Singh Bal
Chief Financial Officer, Executive Vice President and Chief Accounting Officer
On April 4, 2025, Kanwardev Raja Singh Bal notified indie Semiconductor, Inc. (the “Company”) of his resignation as Chief Financial Officer, Executive Vice President and Chief Accounting Officer of the Company.
Departed
Steven R. Burns
Executive Vice President and Chief Administrative Officer
On April 8, 2025, Steven R. Burns, Executive Vice President and Chief Administrative Officer, notified the Company of his intention to retire from the Company, including its Board of Directors, effective on or about April 30, 2025.
Fred W. Wagenhals delivered notice to the Board of Directors of the Company (the “ Board ”) of his resignation from his position as the Executive Chairman of the Company and as Chairman of the Board, effective immediately.
Departed
Ted E. Parker
Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed
Jonathan A. Levy
Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed
M. Ray (Hoppy) Cole, Jr.
Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed
Renee Moore
Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
On April 6, 2025, Edward M. Christie, III, President, Chief Executive Officer and director of Spirit Aviation Holdings, Inc. (the “Company”), stepped down from his role with the Company and the Board of Directors (the “Board”).
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
On April 7, 2025, NRG Energy, Inc. (the “Company”) issued a press release announcing that Rasesh Patel, Executive Vice President, NRG Consumer, has notified the Company of his retirement from the Company, effective May 19, 2025.
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.
Departed
Michael Gibbs
Senior Vice President, General Counsel and Corporate Secretary
T2 Biosystems, Inc.
Effective
2025-03-18
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 18, 2025, Michael Gibbs notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Senior Vice President, General Counsel and Corporate Secretary.
Departed
Laura Adams
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sperzel
Chief Executive Officer and President
T2 Biosystems, Inc.
Effective
2025-03-31
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
Departed
John W. Cumming
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
Robin Toft
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Departed
Seymour Liebman
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
David Elsbree
Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sprague
Chief Financial Officer and Corporate Treasurer
T2 Biosystems, Inc.
Effective
2025-04-03
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
Departed
John Sperzel
Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Effective April 4, 2025, Christopher R. Delaney, President, Europe, Middle East and Africa (“EMEA”), is on a leave of absence from his position with The Goodyear Tire & Rubber Company (the “Company”).
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
On April 4, 2025, Rodney Adkins informed PayPal Holdings, Inc. (“PayPal” or the “Company”) that he will not stand for re-election to PayPal’s Board of Directors (“Board”) when his current term expires at PayPal’s 2025 Annual Meeting of Stockholders (“2025 Annual Meeting”).
In addition, on April 2, 2025, Glenn P. Marino notified the Company of his decision to retire from the Board immediately following the 2025 Annual Meeting.
On April 2, 2025, Vikram A. Atal, President and Chief Executive Officer of PRA Group, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and as a member of the Board, effective on June 17, 2025, immediately following the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
Departed
Scott D. Deverell
Corporate Controller and Principal Accounting Officer
On April 1, 2025, Scott D. Deverell notified Transcat, Inc. (the “Company”) of his intention to retire from his position as Corporate Controller and Principal Accounting Officer of the Company.
On April 2, 2025, David Lazar resigned as President and as member of the Board of Directors (the “Board”) of the Company, with such resignation becoming effective April 2, 2025
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Departed
Andrew Kucharchuk
Chief Financial Officer and member of the Board of Directors
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On the Closing Date, April 1, 2025, Mr. Takehiro Abe resigned from his positions as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
Departed
Takehiro Abe
Director
AIS Holdings Group, Inc.
Successor
Ryohei Uetaki
Filed
April 7, 2025, 7:59 PM ET
Additionally, Mr. Abe resigned from his role as Director, with his resignation becoming effective on the 10th day after the mailing of the Company’s information statement on Schedule 14F-1 to the Company’s stockholders.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.